Tune in as Dr. Tiago Biachi, MD, from Moffitt Cancer Center, explores the latest advancements in immunotherapy for gastroesophageal cancer. In this episode, he breaks down key clinical trial data, examines emerging treatment strategies, and discusses the evolving role of immunotherapy in improving patient outcomes. Don’t miss this expert insight into the future of cancer care!

Tune in for Part 2 of Updates in IDHm Gliomas with FLASCO Neuro-Oncology Captain, Ashley Ghiaseddin, MD, FAAN. This informative podcast covers current and emerging treatments, the evolving role of IDH inhibitors, and the key challenges in treatment, including resistance and tumor heterogeneity. Whether you’re a clinician, researcher, or oncology professional, this FLASCO OncoPod provides valuable insights to enhance patient care and clinical strategies. Listen now to stay at the forefront of glioma treatment advancements!

Join FLASCO for Part I of Updates in IDHm Gliomas with FLASCO Neuro-Oncology Captain, Ashley Ghiaseddin, MD, FAAN. This informative podcast covers current and emerging treatments, the evolving role of IDH inhibitors, and the key challenges in treatment, including resistance and tumor heterogeneity. Whether you’re a clinician, researcher, or oncology professional, this FLASCO OncoPod provides valuable insights to enhance patient care and clinical strategies. Listen now to stay at the forefront of glioma treatment advancements!

In this installment of the FLASCO OncoPod, we explore the critical role of Minimal Residual Disease (MRD) testing in advancing cancer care with Dr. Ivan Borrello, a distinguished oncologist from Tampa General Hospital.

Dr. Borrello dives into the science behind MRD testing, its applications in hematologic malignancies, and how it informs treatment decisions and long-term patient outcomes. Gain expert insights on the latest advancements in MRD technology and its impact on precision medicine in oncology.

Join us for an enlightening conversation designed for oncology professionals dedicated to staying at the forefront of cancer diagnostics and care.

In this episode of the FLASCO OncoPod, we are joined by renowned oncologist Dr. Edgardo Santos, MD, FACP, FCCP, FASCO, from The Oncology Institute of Hope and Innovation (TOI) to discuss the latest updates in lung cancer care.

Dr. Santos shares insights into groundbreaking research, advancements in treatment protocols, and the evolving landscape of lung cancer management. From targeted therapies to immunotherapy breakthroughs, this episode provides a comprehensive look at the innovations improving outcomes for patients.

Don’t miss this engaging discussion designed to inform and inspire oncology professionals across Florida and beyond. Tune in for cutting-edge updates in lung cancer care!

In this episode of the FLASCO OncoPod, we delve into the Management and Treatment of Polycythemia Vera (PV) with expert insights from Dr. Andrew Kuykendall, a leading hematologist from Moffitt Cancer Center.

Join us as Dr. Kuykendall explores the latest advancements in PV care, including symptom management, therapeutic strategies, and emerging research that is shaping the future of treatment. Whether you're a clinical oncologist, a healthcare professional, or simply interested in hematologic cancers, this episode provides valuable knowledge and practical takeaways.

Introducing the first-ever FLASCO OncoPod! Join FLASCO President, Dr. Maen Hussein, as he dives into the critical role state oncology societies play in advancing cancer care. In this inaugural episode, Dr. Hussein discusses the importance of becoming an active member of your state society, sharing how FLASCO stands as a dedicated supporter and advocate for oncology professionals across Florida. From educational programs to networking opportunities and legislative advocacy, learn how FLASCO continues to empower oncologists, pharmacists, nurses, and allied professionals, helping them navigate the ever-evolving landscape of cancer care. Tune in to be inspired and get involved!